Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Purdue Pharma L.P. is currently managing 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 6 distinct examiners, meaning each examiner is responsible for exactly one of the pending matters. The portfolio is spread across 4 distinct art units, suggesting that while the examiners are all different, some of them are working within the same administrative divisions at the USPTO.
The busiest examiner for Purdue Pharma L.P. is TCHERKASSKAYA, OLGA V, who is responsible for 1 busiest examiner pending office action. Since there are 6 pending office actions and 6 distinct examiners, the workload is balanced with one action per person. For a practitioner, the presence of 4 distinct art units for 6 pending office actions indicates a moderate level of technical diversity. The strategy should account for the fact that each of the 6 pending office actions is being reviewed by a different individual, even when those individuals are in the same art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (67%) |
| §112 only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TCHERKASSKAYA, OLGA V | 1 | 55.4% | +46.2% |
| HAM, JIEUN | 1 | 50.0% | +8.8% |
| KENYON, JOHN S | 1 | 79.7% | +18.3% |
| YOUNG, MICAH PAUL | 1 | 55.1% | +30.0% |
| MACH, ANDRE | 1 | 44.9% | +51.7% |
| COPPINS, JANET L | 1 | 72.6% | +26.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17910199 | COMPOSITIONS AND METHODS FOR NALOXONE DELIVERY | YOUNG, MICAH PAUL | 6d |
| 18746814 | PHARMACEUTICAL DOSAGE FORMS | TCHERKASSKAYA, OLGA V | — |
| 18389356 | COMPOSITIONS AND METHODS FOR OPIOID ANTAGONIST DELIVERY | KENYON, JOHN S | — |
| 17918012 | COMPOSITIONS AND METHODS FOR EMERGENCY RESCUE | MACH, ANDRE | — |
| 17059761 | COMPOSITIONS AND METHODS FOR OPIOID OVERDOSE RESCUE | COPPINS, JANET L | — |
| Art Unit | Apps |
|---|---|
| 1615 | 2 |
| 1625 | 1 |
| 1618 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18746814 | PHARMACEUTICAL DOSAGE FORMS | TCHERKASSKAYA, OLGA V | 1615 | §112Other | Final Rejection | — | Pending | Jun 18, 2024 |
| 18420883 | COMBINATIONS FOR TREATING CANCER | HAM, JIEUN | — | §103 | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18389356 | COMPOSITIONS AND METHODS FOR OPIOID ANTAGONIST DELIVERY | KENYON, JOHN S | 1625 | §102DP | Non-Final OA | — | Pending | Nov 14, 2023 |
| 17910199 | COMPOSITIONS AND METHODS FOR NALOXONE DELIVERY | YOUNG, MICAH PAUL | 1618 | §103 | Final Rejection | 6d | Pending | Feb 22, 2023 |
| 17918012 | COMPOSITIONS AND METHODS FOR EMERGENCY RESCUE | MACH, ANDRE | 1615 | §103 | Final Rejection | — | Pending | Oct 10, 2022 |
| 17059761 | COMPOSITIONS AND METHODS FOR OPIOID OVERDOSE RESCUE | COPPINS, JANET L | 1628 | §103 | Final Rejection | — | Pending | Nov 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial